WGS

GeneDx Holdings (WGS)

About GeneDx Holdings (WGS)

GeneDx Holdings Corp. operates as a health intelligence company. It engages in healthcare with the use of its collected disease data sets. It offers exome and genome testing for diagnosis of genetic disease. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

Details

Daily high

$164.22

Daily low

$158.99

Price at open

$160.38

52 Week High

$170.87

52 Week Low

$55.17

Market cap

4.6B

Dividend yield

0.00%

Volume

246,438

Avg. volume

514,821

P/E ratio

2,659.62

GeneDx Holdings News